Its the same with keto, it can be risky to come up with entirely new products for a trend you dont know will last, but if you position existing products as keto-friendly, you can still cash in. Rabobank: This is just the beginning While its still early days, the GLP-1 market has been able to grow so dramatically because of the unanticipated role of FDA-registered compounding pharmacies that have helped to help fill the supply gap created by producing cheaper copies of these medications, said Nick Fereday, executive director, food & consumer trends at Rabobank in a recent analysis
What to expect: Brief return of mild side effects during the first week or two at the new dose, then continued steady progress
Over-the-counter CGMs such as Abbotts Libre Rio now retail in high-street pharmacies without prescriptions, expanding penetration beyond endocrinology clinics
By choosing a high-quality supplement like Henry Blooms Acetyl L-Carnitine 500, youre supporting your bodys natural energy systems, helping deliver sustained energy, rather than turning to a quick pick-me-up [2]
When approved options may arrive CagriSema may reach the market within the next one to two years based on current trial timelines and regulatory trajectories
People with obesity typically lose about 15% of their body weight on Zepbound, and about 25% of the total weight lost may come from lean mass